Updating CAR-T Cell Immunotherapy for Liquid and Solid Tumor
Journal Title: Diseases & Research - Year 2023, Vol 3, Issue 2
Abstract
According to the GLOBOCAN 2020 report, there is still a 50% mortality rate observed in cancer patients despite the availability of various innovative cancer therapies. This highlights the need for specific therapies that can effectively kill cancer cells without harming normal cells. One such therapy is cancer immunotherapy, which comprises immune checkpoint blockade, adoptive cellular therapies, cancer vaccines, and CAR-T cell therapy. CAR-T cell therapy entails modifying T-cells from a cancer patient in a lab so that they attack cancer cells only. This therapy has been successful in treating some lymphomas and myelomas, and is being explored for solid tumors as well. However, there are certain limitations to its efficacy for solid tumors due to their heterogeneity. This review covers the most recent advancements and enhancements in CAR-T therapies for lymphomas and solid tumors, as well as methods to get around their drawbacks.
Authors and Affiliations
Ankita Singh, Pravin D. Potdar
Keywords
Related Articles
- EP ID EP740180
- DOI 10.54457/DR.202302005
- Views 76
- Downloads 2
Efficacy of Platelet-Rich Plasma Combined with Wen Shen Formula in the Treatment of Thin Endometrium-Related Infertility
Objective To explore the effectiveness of Platelet-Rich Plasma (PRP) combined with Wen Shen Formula in treating thin endometrium. Methods From January 2019 to January 2023, 90 patients with thin endometrium-related infe...
Angioimmunoblastic T Cell Lymphoma Complicated by Cirrhosis Decompensation
A 55-year-old male with a history of hepatitis B was hospitalized for persistent cough, fever, rash, and abdominal bloating. Despite treatment for suspected respiratory infection with multiple antibiotics, his symptoms w...
Determination of mRNA Targets of miR-376c within the RNA-Induced Silencing Complex
Background The focus of the present study was to establish an easy combined method based on the MirTrap system together with a mRNA array to efficiently define target mRNAs which can be bound by miR-376 within the RNA-in...
Is Preoperative Radiotherapy Necessary for Resectable Locally Advanced Squamous Cell Esophageal Carcinoma?
Based on the guidelines for esophageal and esophagogastric junction cancers, the standard of care for resectable locally advanced (cT2, N0 [high-risk lesions: lymphovascular invasion, ≥3 cm, poorly differentiated]; cT1b-...
The Clinical Feature of Chronic Hepatitis B Patients with High HBV pgRNA
ackground and Aims At present, nucleos(t)ide analogue (NA) is usually used to treat chronic hepatitis B, but there are still some patients with high levels of pgRNA after long-term treatment. We tried to study the clinic...